Alpha Centric Advisors LLC Albemarle Corp Transaction History

Alpha Centric Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$162.63 - $243.44 $4,553 - $6,816	-28 Reduced 14.51%	165 $28,000
Q2 2023 Aug 08, 2023	SELL	$172.91 - $232.22 $1,210 - $1,625	-7 Reduced 3.5%	193 $43,000
Q1 2023 May 12, 2023	SELL	$208.49 - $290.15 $2,084 - $2,901	-10 Reduced 4.76%	200 $44,000
Q4 2022 Feb 07, 2023	BUY	$214.02 - $325.38 $44,944 - $68,329	210 New	210 $46,000

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.